US Broker Ratings

Elanco Animal Health (ELAN): Strong Buy Ratings and 14% Upside Potential

Elanco Animal Health Incorporated (NYSE: ELAN) is capturing investor attention with its robust position in the healthcare sector, specifically within the drug manufacturing industry for specialty and generic products. With..

Bausch + Lomb Corporation (BLCO) Investor Outlook: Analyzing Its 9.65% Potential Upside

Bausch + Lomb Corporation (NYSE: BLCO), a venerable name in the healthcare sector with roots dating back to 1853, continues to capture investor interest with its promising market position in..

Globus Medical, Inc. (GMED) Stock Analysis: Unveiling a 31.90% Potential Upside in the Healthcare Sector

Investors with an interest in the healthcare sector, particularly the medical devices industry, may find Globus Medical, Inc. (NYSE: GMED) worth considering. This Pennsylvania-based company, with a market capitalization of..

Dr. Reddy’s Laboratories Ltd (RDY): Investor Outlook Reveals 14% Potential Upside in Healthcare Sector

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), an Indian pharmaceutical giant, stands as a compelling prospect for investors navigating the healthcare sector. With a market capitalization of $9.87 billion, Dr. Reddy’s..

Genmab A/S (GMAB) Stock Analysis: A 31.49% Potential Upside in the Biotech Sector

For investors eyeing the biotechnology sector, Genmab A/S (NASDAQ: GMAB) presents a compelling opportunity. With an impressive $17.72 billion market cap, this Danish biotech powerhouse is making significant strides in..

ADMA Biologics Inc (ADMA) Stock Analysis: A Look at Its 100.95% Potential Upside

As the healthcare sector continues to be a focal point for investors seeking growth opportunities, ADMA Biologics Inc (NASDAQ: ADMA) emerges as a noteworthy contender within the biotechnology industry. Headquartered..

Glaukos Corporation (GKOS) Stock Analysis: High Growth Prospects with a 16% Potential Upside

Glaukos Corporation (NYSE: GKOS), a prominent player in the medical devices sector focused on ophthalmic solutions, is currently capturing the attention of investors with its robust growth metrics and considerable..

Repligen Corporation (RGEN) Investor Outlook: Exploring the 31.69% Potential Upside

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, specializes in medical instruments and supplies. With a market capitalization of $7.96 billion, Repligen is a leading innovator in..

Cytokinetics, Incorporated (CYTK) Stock Analysis: A 39.76% Potential Upside Sparks Investor Interest

Cytokinetics, Incorporated (NASDAQ: CYTK) is capturing the attention of investors with a compelling growth narrative in the biotechnology sector, coupled with an impressive potential upside of 39.76%. As a key..

Encompass Health Corporation (EHC) Stock Analysis: A Strong Buy with 26.5% Potential Upside

Encompass Health Corporation (NYSE: EHC) stands as a formidable player in the healthcare sector, specifically within the medical care facilities industry. Operating primarily in the United States and Puerto Rico,..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a 8.75% Potential Downside Amidst Strong Sector Position

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, has built a robust reputation in the medical devices industry. The company, headquartered in Hercules, California, is renowned..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a Potential 17% Upside

Merit Medical Systems, Inc. (NASDAQ: MMSI) has emerged as a compelling investment opportunity within the healthcare sector, specifically in the medical instruments and supplies industry. Headquartered in South Jordan, Utah,..

Alkermes plc (ALKS) Stock Analysis: A Compelling 14% Upside Potential for Investors

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, presents an intriguing case for investors. With its headquarters in..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating the Healthcare Device Market with Robust Analyst Support

Integer Holdings Corporation (NYSE: ITGR), a key player in the medical device sector, has captured the attention of investors with its robust market presence and consistent performance in the healthcare..

Stevanato Group S.p.A. (STVN) Stock Analysis: A Healthcare Giant with a 23% Potential Upside

Stevanato Group S.p.A. (NYSE: STVN) is a notable player within the healthcare sector, specifically in medical instruments and supplies. With its headquarters in Piombino Dese, Italy, the company is a..

Biogen Inc. (BIIB) Stock Analysis: Potential 15% Upside Amidst Robust Drug Portfolio

Biogen Inc. (NASDAQ: BIIB), a heavyweight in the healthcare sector, is a key player in the drug manufacturing industry with a market capitalization of $29.99 billion. Despite a slight price..

Inspire Medical Systems (INSP) Stock Analysis: Investor Outlook Amid a 2.43% Potential Upside

In the dynamic world of healthcare, Inspire Medical Systems, Inc. (NASDAQ: INSP) stands out as a pioneering force in the medical devices industry. With a market capitalization of $1.45 billion,..

Guardant Health, Inc. (GH) Stock Analysis: Impressive Revenue Growth Fuels Investor Optimism

Guardant Health, Inc. (NASDAQ: GH), a trailblazer in the field of precision oncology, continues to captivate investor interest with its remarkable 44.30% revenue growth. This substantial uptick underscores the company’s..

TransMedics Group, Inc. (TMDX) Stock Analysis: Healthcare Innovator with 43% Upside Potential

TransMedics Group, Inc. (NASDAQ: TMDX) stands at the forefront of revolutionizing organ transplant therapies with its innovative Organ Care System (OCS). As a commercial-stage medical technology company, TransMedics specializes in..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Potential 26.46% Upside as Healthcare Innovator Eyes Growth

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a frontrunner in the healthcare sector specializing in diagnostics and research, stands as a compelling investment opportunity with a market cap of $44.1 billion. The..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds